Terms: = Leukemia AND BCL3, P20749, 602, ENSG00000069399, D19S37, BCL4
164 results:
1. Exploring the role of GHRH antagonist MIA-602 in overcoming Doxorubicin-resistance in acute myeloid leukemia.
Gaumond SI; Abdin R; Costoya J; Schally AV; Jimenez JJ
Oncotarget; 2024 Apr; 15():248-254. PubMed ID: 38588464
[TBL] [Abstract] [Full Text] [Related]
2. Diverse B-cell tumors associated with t(14;19)(q32;q13)/IGH::bcl3 identified by G-banding and fluorescence in situ hybridization.
Ohno H; Maekawa F; Hayashida M; Nakagawa M; Fukutsuka K; Matsumura M; Takeoka K; Maruyama W; Ukyo N; Sumiyoshi S; Tanaka Y; Haga H
J Clin Exp Hematop; 2024; 64(1):21-31. PubMed ID: 38538317
[TBL] [Abstract] [Full Text] [Related]
3. ADCT-602, a Novel PBD Dimer-containing Antibody-Drug Conjugate for Treating CD22-positive Hematologic Malignancies.
Zammarchi F; Havenith KE; Sachini N; Janghra N; Chivers S; Idusogie E; Gaudio E; Tarantelli C; Bertelli F; Santos K; Tyrer P; Corbett S; Spriano F; Golino G; Cascione L; Bertoni F; Hartley JA; van Berkel PH
Mol Cancer Ther; 2024 Apr; 23(4):520-531. PubMed ID: 38324336
[TBL] [Abstract] [Full Text] [Related]
4. Indolent B-cell lymphoma with t(14;19) investigated from a molecular perspective.
Karrs JX; Sathyanarayana SH; Xu X; Green DC; Kahn WA; Loo EY; Kaur P
J Hematop; 2023 Dec; 16(4):217-221. PubMed ID: 38175432
[TBL] [Abstract] [Full Text] [Related]
5. Novel identification of t(14;18)(q32;q21)/IGH::MALT1 in chronic lymphocytic leukaemia.
Kumar J; Ewalt MD; Zhang Y; Yao J; Thompson MC; Dogan A
Br J Haematol; 2024 Feb; 204(2):561-565. PubMed ID: 38031233
[TBL] [Abstract] [Full Text] [Related]
6.
Carbo-Meix A; Guijarro F; Wang L; Grau M; Royo R; Frigola G; Playa-Albinyana H; Buhler MM; Clot G; Duran-Ferrer M; Lu J; Granada I; Baptista MJ; Navarro JT; Espinet B; Puiggros A; Tapia G; Bandiera L; De Canal G; Bonoldi E; Climent F; Ribera-Cortada I; Fernandez-Caballero M; De la Banda E; Do Nascimento J; Pineda A; Vela D; Rozman M; Aymerich M; Syrykh C; Brousset P; Perera M; Yanez L; Ortin JX; Tuset E; Zenz T; Cook JR; Swerdlow SH; Martin-Subero JI; Colomer D; Matutes E; Bea S; Costa D; Nadeu F; Campo E
Haematologica; 2024 Feb; 109(2):493-508. PubMed ID: 37560801
[TBL] [Abstract] [Full Text] [Related]
7. [Clinical characteristics of 11 patients with chronic lymphocytic leukemia with t (14;19) (q32;q13)].
Cui CH; Chang YN; Zhou J; Li CW; Wang HJ; Sun Q; Jia YJ; Li QH; Wang TY; Qiu LG; Yi SH
Zhonghua Xue Ye Xue Za Zhi; 2023 May; 44(5):418-423. PubMed ID: 37550193
[No Abstract] [Full Text] [Related]
8. [Clinical analysis of 20 cases of small B lymphocyte proliferative disease with t (14;19) (q32;q13)].
Yang H; Guo R; Shi Y; Qiao C; Wu YJ; Fan L; Xu W; Miao KR; Li JY; Qiu HR
Zhonghua Xue Ye Xue Za Zhi; 2022 Aug; 43(8):674-679. PubMed ID: 36709153
[No Abstract] [Full Text] [Related]
9. Features of Epstein-Barr Virus and Cytomegalovirus Reactivation in Acute leukemia Patients After Haplo-HCT With Myeloablative ATG-Containing Conditioning Regimen.
Ru Y; Zhu J; Song T; Ding Y; Zhu Z; Fan Y; Xu Y; Sun A; Qiu H; Jin Z; Tang X; Han Y; Fu C; Chen S; Ma X; Chen F; Chen J; Wu D
Front Cell Infect Microbiol; 2022; 12():865170. PubMed ID: 35651756
[TBL] [Abstract] [Full Text] [Related]
10. Clinical outcomes in patients with relapsed/refractory FLT3-mutated acute myeloid leukemia treated with gilteritinib who received prior midostaurin or sorafenib.
Perl AE; Hosono N; Montesinos P; Podoltsev N; Martinelli G; Panoskaltsis N; Recher C; Smith CC; Levis MJ; Strickland S; Röllig C; Groß-Langenhoff M; Chou WC; Lee JH; Yokoyama H; Hasabou N; Lu Q; Tiu RV; Altman JK
Blood Cancer J; 2022 May; 12(5):84. PubMed ID: 35637252
[TBL] [Abstract] [Full Text] [Related]
11. Rare t(X;14)(q28;q32) translocation reveals link between MTCP1 and chronic lymphocytic leukemia.
Walker JS; Hing ZA; Sher S; Cronin J; Williams K; Harrington B; Skinner JN; Cempre CB; Gregory CT; Pan A; Yano M; Beaver LP; Walker BR; Labanowska JM; Heerema NA; Mrózek K; Woyach JA; Ruppert AS; Lehman A; Ozer HG; Coppola V; Yan P; Byrd JC; Blachly JS; Lapalombella R
Nat Commun; 2021 Nov; 12(1):6338. PubMed ID: 34732719
[TBL] [Abstract] [Full Text] [Related]
12. Evaluation of arsenic species in leukocytes and granulocytes of acute promyelocytic leukemia patients treated with arsenic trioxide.
Wang X; Qian Z; Li H; Chen H; Lin L; Guo M; Hai X
J Pharm Biomed Anal; 2021 Sep; 203():114201. PubMed ID: 34130006
[TBL] [Abstract] [Full Text] [Related]
13. Safety and efficacy profile of mogamulizumab (Poteligeo) in the treatment of cancers: an update evidence from 14 studies.
Zhang T; Sun J; Li J; Zhao Y; Zhang T; Yang R; Ma X
BMC Cancer; 2021 May; 21(1):618. PubMed ID: 34039310
[TBL] [Abstract] [Full Text] [Related]
14. BCL-3 and β-catenin signaling and tumor staging in colorectal cancer.
Zhang S; Yin C
Cell Mol Biol (Noisy-le-grand); 2020 Jul; 66(5):87-91. PubMed ID: 33040819
[TBL] [Abstract] [Full Text] [Related]
15. Treatment outcomes in children with Acute lymphoblastic leukemia with versus without coexisting Down's syndrome: A systematic review and meta-analysis.
Liao W; Liu Y
Medicine (Baltimore); 2020 Jul; 99(29):e21015. PubMed ID: 32702842
[TBL] [Abstract] [Full Text] [Related]
16. BCL‑3 promotes cyclooxygenase‑2/prostaglandin E2 signalling in colorectal cancer.
Collard TJ; Fallatah HM; Greenhough A; Paraskeva C; Williams AC
Int J Oncol; 2020 May; 56(5):1304-1313. PubMed ID: 32319612
[TBL] [Abstract] [Full Text] [Related]
17. The prognostic effect of smoking status on intensively treated acute myeloid leukaemia - A Danish nationwide cohort study.
Kristensen D; Nielsen LB; Roug AS; Kristensen TC; El-Galaly TC; Nørgaard JM; Marcher CW; Schöllkopf C; Theilgaard-Mönch K; Severinsen MT
Br J Haematol; 2020 Jul; 190(2):236-243. PubMed ID: 32316076
[TBL] [Abstract] [Full Text] [Related]
18. MEC (mitoxantrone, etoposide, and cytarabine) induces complete remission and is an effective bridge to transplant in acute myeloid leukemia.
Marconi G; Talami A; Abbenante MC; Sartor C; Parisi S; Nanni J; Bertamini L; Ragaini S; Olivi M; de Polo S; Cristiano G; Fontana MC; Bochicchio MT; Ottaviani E; Arpinati M; Sessa M; Baldazzi C; Caso L; Testoni N; Baccarani M; Bonifazi F; Martinelli G; Paolini S; Cavo M; Papayannidis C; Curti A
Eur J Haematol; 2020 Jul; 105(1):47-55. PubMed ID: 32145118
[TBL] [Abstract] [Full Text] [Related]
19. Expression of DOCK10.1 protein revealed with a specific antiserum: insights into regulation of first exon isoforms of DOCK10.
Parrado A
Mol Biol Rep; 2020 Apr; 47(4):3003-3010. PubMed ID: 32112301
[TBL] [Abstract] [Full Text] [Related]
20. The role of B-Cell Lymphoma-3 (BCL-3) in enabling the hallmarks of cancer: implications for the treatment of colorectal carcinogenesis.
Legge DN; Chambers AC; Parker CT; Timms P; Collard TJ; Williams AC
Carcinogenesis; 2020 May; 41(3):249-256. PubMed ID: 31930327
[TBL] [Abstract] [Full Text] [Related]
[Next]
